CD14 and neoplasm: Studies of the same tumor specimens revealed that the majority (∼80%) of tumor-associated DCs (TADCs), defined as CD45+CD11c+HLA-DR+ cells, expressed CD14, which indicates their monocytic origin and likely inclusion among the CD14+ cells associated with Tregs (Figures 6I,J).